HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier Prada Selected Research

Serotonin Antagonists

4/2015Significant decreases of interleukin-1α gene expression after application of the serotonin receptor antagonist ondansetron are found to correlate with antiproliferative properties in the acute lymphoblastic leukemia cell line REH.
5/2011Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier Prada Research Topics

Disease

5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015 - 03/2010
3Leukemia
03/2013 - 03/2010
2Neoplasms (Cancer)
08/2008 - 01/2005
1Philadelphia Chromosome
08/2008
1Ocular Toxoplasmosis
12/2007
1Necrosis
12/2007
1Pancytopenia
02/2007
1VLCAD deficiency
02/2007
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2005

Drug/Important Bio-Agent (IBA)

2Ondansetron (Zofran)FDA LinkGeneric
04/2015 - 05/2011
2Serotonin AntagonistsIBA
04/2015 - 05/2011
1Bortezomib (Velcade)FDA Link
03/2013
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
11/2011
1Biological ProductsIBA
11/2011
1EphrinsIBA
11/2011
1Integrin alpha4beta1 (VLA-4)IBA
11/2011
1Immunoglobulins (Immunoglobulin)IBA
03/2010
1DNA (Deoxyribonucleic Acid)IBA
08/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2008
1Interleukin-6 (Interleukin 6)IBA
12/2007
1OxidesIBA
12/2007
1Mitochondrial DNA (mtDNA)IBA
02/2007
1Chromogranin AIBA
01/2005
1CalciumIBA
01/2005
1Insulin (Novolin)FDA Link
01/2005

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2013 - 03/2010
2Therapeutics
03/2013 - 11/2011
1Secondary Prevention
08/2008